The first report of a Philadelphia chromosome and BCR/ABL rearrangement positive myeloproliferative disorder in a child with thrombocythemia
✍ Scribed by Anguita, E; Valverde, F; González, F A; Gil, C; Mateo, M; Ferro, M T; Villegas, A
- Book ID
- 110053768
- Publisher
- Nature Publishing Group
- Year
- 1998
- Tongue
- English
- Weight
- 44 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The molecular basis of the Philadelphia chromosome (Ph') is a structurally altered c-abl (bcr-abl) gene which encodes an abnormally large protein with protein tyrosine kinase activity. Herbimycin A, which effectively reduced intracellular phosphorylation by bcr-abl tyrosine kinase, preferentially in
FL 33612 to permit rapid consideration for publication. ## Mutations in the Factor XI Gene To the Editor: Mutations in the factor XI gene are responsible for a variable bleeding phenotype which correlates poorly with levels of circulating FXI product. We read with interest and concern an article
## Abstract Constitutive activation of tyrosine kinases as a consequence of chromosomal translocations, forming fusion genes, plays an important role in the development of hematologic malignancies, in particular, myeloproliferative syndromes (MPSs). In this respect, the t(9;22)(q34;q11) that result